383 related articles for article (PubMed ID: 36209703)
1. Evaluating Cannabis sativa L.'s neuroprotection potential: From bench to bedside.
Laws JS; Smid SD
Phytomedicine; 2022 Dec; 107():154485. PubMed ID: 36209703
[TBL] [Abstract][Full Text] [Related]
2. Characterizing cannabis-prevalent terpenes for neuroprotection reveal a role for α and β-pinenes in mitigating amyloid β-evoked neurotoxicity and aggregation in vitro.
Laws JS; Smid SD
Neurotoxicology; 2024 Jan; 100():16-24. PubMed ID: 38070653
[TBL] [Abstract][Full Text] [Related]
3. Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells.
Laws Iii JS; Shrestha S; Smid SD
Neurotoxicology; 2022 May; 90():81-87. PubMed ID: 35278524
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical Constituents and Derivatives of
Schanknecht E; Bachari A; Nassar N; Piva T; Mantri N
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614303
[TBL] [Abstract][Full Text] [Related]
5. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.
Bonini SA; Premoli M; Tambaro S; Kumar A; Maccarinelli G; Memo M; Mastinu A
J Ethnopharmacol; 2018 Dec; 227():300-315. PubMed ID: 30205181
[TBL] [Abstract][Full Text] [Related]
6. The Neurotherapeutic Arsenal in
Al-Khazaleh AK; Zhou X; Bhuyan DJ; Münch GW; Al-Dalabeeh EA; Jaye K; Chang D
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257323
[TBL] [Abstract][Full Text] [Related]
7. Terpenoids, Cannabimimetic Ligands, beyond the
Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
[TBL] [Abstract][Full Text] [Related]
8.
Stasiłowicz A; Tomala A; Podolak I; Cielecka-Piontek J
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466734
[No Abstract] [Full Text] [Related]
9. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
Nigro E; Formato M; Crescente G; Daniele A
Molecules; 2021 May; 26(9):. PubMed ID: 34063214
[No Abstract] [Full Text] [Related]
10. Constituents of Cannabis Sativa.
Rock EM; Parker LA
Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
[TBL] [Abstract][Full Text] [Related]
11. Cannabis Sativa L. Flower and Bud Extracts Inhibited In vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease.
Mooko T; Bala A; Tripathy S; Kumar CS; Mahadevappa CP; Chaudhary SK; Matsabisa MG
Endocr Metab Immune Disord Drug Targets; 2022; 22(3):297-309. PubMed ID: 33618651
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases.
Prandi C; Blangetti M; Namdar D; Koltai H
Molecules; 2018 Jun; 23(7):. PubMed ID: 29941830
[No Abstract] [Full Text] [Related]
13. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases.
Pérez-Olives C; Rivas-Santisteban R; Lillo J; Navarro G; Franco R
Adv Exp Med Biol; 2021; 1264():81-92. PubMed ID: 33332005
[TBL] [Abstract][Full Text] [Related]
14. Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid β-mediated neurotoxicity in PC12 cells: Comparison with geranylated flavonoids, mimulone and diplacone.
Eggers C; Fujitani M; Kato R; Smid S
Biochem Pharmacol; 2019 Nov; 169():113609. PubMed ID: 31437460
[TBL] [Abstract][Full Text] [Related]
15. Phytocannabinoids beyond the Cannabis plant - do they exist?
Gertsch J; Pertwee RG; Di Marzo V
Br J Pharmacol; 2010 Jun; 160(3):523-9. PubMed ID: 20590562
[TBL] [Abstract][Full Text] [Related]
16. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
[TBL] [Abstract][Full Text] [Related]
17. Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases.
Dos Reis Rosa Franco G; Smid S; Viegas C
Curr Neuropharmacol; 2021; 19(4):449-464. PubMed ID: 32691712
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds.
Lins BR; Anyaegbu CC; Hellewell SC; Papini M; McGonigle T; De Prato L; Shales M; Fitzgerald M
J Neuroinflammation; 2023 Mar; 20(1):77. PubMed ID: 36935484
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Cannabinoid System in Alzheimer's Disease.
Li S; Huang Y; Yu L; Ji X; Wu J
Curr Neuropharmacol; 2023; 21(3):715-726. PubMed ID: 35105293
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.
Coles M; Steiner-Lim GZ; Karl T
Front Neurosci; 2022; 16():962922. PubMed ID: 36117622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
